TODAY'S HEADLINES

New leukemia drug available

FDA recently approved venetoclax (Venclexta, AbbVie and Genentech) to treat chronic lymphocytic leukemia (CLL) in patients who have a chromosomal abnormality called 17p deletion and who have been treated with at least one prior therapy. Read more

FDA committee recommends approving rare liver disease drug

An FDA advisory committee recently voted to recommend approval of obeticholic acid (Ocaliva, Intercept Pharmaceuticals, Inc.) for the treatment of primary biliary cholangitis (PBC). If approved, Ocaliva would be the first new treatment for PBC in nearly 20 years. Read more

CONTINUING PHARMACY EDUCATION

The expanding role of direct oral anticoagulants in the management of thromboembolic disease

This month's CE activity is open for pharmacists and pharmacy technicians: "The expanding role of direct oral anticoagulants in the management of thromboembolic disease." Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

Controversy surrounds abortion pill access

Soon after FDA expanded access to the "abortion pill" or mifepristone (Mifeprex, Danco Laboratories), some states may be combating the decision. Find out which state requires abortion clinics to use mifepristone before a woman is 7 weeks pregnant. Read more

April 15, 2016

National Managed Care Pharmacy Survey 2016

Your input is needed! Managed Healthcare Executive, in partnership with Access Market Intelligence and the National Institute of Collaborative Healthcare, is seeking your opinion on the current state of pharmacy. Take the survey and you could win a $200 Visa gift card. Answer Now.

Related Articles

Leukemia drug gets US OK, struggles in UK

FDA approves Bayer hemophilia A drug